Screening for novel urinary EV lncRNA candidates for bladder cancer diagnosis identified MALAT1, PCAT-1, and SPRY4-IT1 differential expression to be of high diagnostic value in a training set consisting of 208 urine samples, which was subsequently confirmed in a validation set (160 urine samples) [78]. The gene discussed is SPRY4; the disease is urinary bladder cancer.